Company Profiles

driven by the PitchBook Platform

Absynth Biologics

Absynth Biologics
2007 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Crowdfunding LATEST DEAL TYPE (Announced)
$481k LATEST DEAL AMOUNT
$4.98M TOTAL AMOUNT RAISED
Description

Developer of vaccines and antibodies to treat bacterial infections. The company's products are based on a platform for identifying protein antigen targets that harness the immune system.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare
Primary Office
BioHub at Alderley Park
Alderley Edge
Cheshire SK10 4TG
England

+44 (0)16 2523 8805
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Absynth Biologics’s full profile, request a free trial.

Absynth Biologics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Product Crowdfunding 20-Sep-2017 $481k $4.98M Announced Generating Revenue
7. Later Stage VC 30-Nov-2015 00.00 Cancelled Generating Revenue
6. Later Stage VC 30-Nov-2015 00000 00.000 Completed Generating Revenue
5. Later Stage VC 24-Jul-2014 00.00 00.00 00.000 Completed Generating Revenue
4. Later Stage VC 10-Jul-2013 00.000 000 00.000 Completed Generating Revenue
3. Grant 01-Jan-2012 00000 00000 Completed Stealth
2. Early Stage VC 31-Jul-2007 $284k $714k Completed Stealth
1. Convertible Debt $429k $429k Completed Stealth
To view this company’s complete deal history including valuation and funding request access »

Absynth Biologics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary B 00 00.000000 000000.00 000000.00 00 000000.00 00.000
Ordinary A 00 00.000000 000000.0 000000.0 00 000000.0 00.000
To view this company’s complete Cap Table request access »

Absynth Biologics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BioCity Nottingham Venture Capital Minority 000 0000 000000 0
IP Group United Kingdom Venture Capital Minority 000 0000 000000 0
Innovate UK Accelerator/Incubator 000 0000 000000 0
O2h Ventures Other Minority 000 0000 000000 0
Spark Impact Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Absynth Biologics Executive Team (3)

Name Title Board
Seat
Contact
Info
Fiona Marston Ph.D Chief Executive & Board Member
Simon Foster Chief Scientific Officer, Co-Founder & Board Member
Mark Hollingworth Director, Finance

Absynth Biologics Board Members (4)

Name Representing Role Since Contact
Info
David Knowles Self Chairman 000 0000
Fiona Marston Ph.D Absynth Biologics Chief Executive & Board Member 000 0000
Marc D'Abbadie Ph.D Spark Impact Board Member 000 0000
Peter Grant Ph.D Self Board Member 000 0000